Silo Pharma Stock Investor Sentiment

SILO Stock  USD 1.36  0.02  1.45%   
About 62% of Silo Pharma's investor base is looking to short. The analysis of current outlook of investing in Silo Pharma suggests that many traders are alarmed regarding Silo Pharma's prospects. Silo Pharma's investing sentiment overview a quick insight into current market opportunities from investing in Silo Pharma. Many technical investors use Silo Pharma stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
over six months ago at news.google.com         
Silo Pharmas Promising Developments and Key Insights for Traders and Investors - Barchart
Google News at Macroaxis
over six months ago at news.google.com         
Short Interest in Silo Pharma, Inc. Decreases By 26.4 percent - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Silo Pharma Trading Up 7.4 percent - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Silo Pharma reports progress in depression treatment study - Investing.com
Google News at Macroaxis
over six months ago at news.google.com         
Silo Pharma to Participate in FDA Meeting Exploring Emerging Therapeutic Interest in Ketamine - Yaho...
Google News at Macroaxis
over six months ago at news.google.com         
Silo Pharma reports promising SPC-15 study for PTSD therapy By Investing.com - Investing.com Nigeria
Google News at Macroaxis
over six months ago at forbes.com         
A Decade On, Silos Zero-Waste Chef Douglas McMaster Shares Hopes, Doubts
Usa forbes News
over six months ago at www.macroaxis.com         
Insider Trading
Macroaxis News
over six months ago at news.google.com         
Silo Pharma Advances Alzheimers Disease Treatment with SPC-14 - The Dales Report
Google News at Macroaxis
over six months ago at globenewswire.com         
Silo Pharma set to Acquire Exclusive Licensing for Promising Alzheimers Disease Therapeutic
Macroaxis News: globenewswire.com
over six months ago at investing.com         
Silo Pharma secures Alzheimers disease therapeutic license
Investing News at Macroaxis
over six months ago at seekingalpha.com         
Silo Pharma set to acquire licensing for Alzheimers disease therapeutic
seekingalpha News
over six months ago at finance.yahoo.com         
Silo Pharma set to Acquire Exclusive Licensing for Promising Alzheimers Disease Therapeutic
Yahoo News
over six months ago at benzinga.com         
Citizens And 2 Other Stocks Under 3 Insiders Are Buying
benzinga news
over six months ago at investing.com         
Silo Pharma CEO buys shares worth 1,988
Investing News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Silo Pharma that are available to investors today. That information is available publicly through Silo media outlets and privately through word of mouth or via Silo internal channels. However, regardless of the origin, that massive amount of Silo data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Silo Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Silo Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Silo Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Silo Pharma alpha.

Silo Pharma Performance against Dow Jones

 Price Growth (%)  
JavaScript chart by amCharts 3.21.15Dec2025Feb 020406080100120
JavaScript chart by amCharts 3.21.15Silo Pharma Silo Pharma Dividend Benchmark Dow Jones Industrial
       Timeline  

Other Information on Investing in Silo OTC Stock

Silo Pharma financial ratios help investors to determine whether Silo OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Silo with respect to the benefits of owning Silo Pharma security.